An article in the November 20, 2008 edition of the New England Journal of Medicine reports the results from a large, randomized study designed to assess the relationship between statin treatment and cardiovascular disease (as indicated by having at least one of several clinical endpoints). The researchers randomized 17,800 healthy (without a history of cardiovascular disease) men and women with non- elevated LDL cholesterol levels to either 20 mg of statins daily, or placebo. Subjects were followed for up to 5 years. At the end of the follow-up period the study results included the following: Of the 8900 subjects randomized to the statins group, 142 developed cardiovascular disease. Of the 8900 subjects randomized to the placebo group, 251 developed cardiovascular disease. (Reference: Ridker P, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine. (2008). 359;21) What is the estimated relative risk of developing cardiovascular disease for subjects in the statins group compared to subjects on placebo? The estimated relative risk is approximately - 0.012. O The estimated relative risk is approximately 1.77 O The estimated relative risk is approximately 0.57. The estimated relative risk is approximately 0.012.

MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
icon
Related questions
Question
100%

its public health statistics only answer needed

7. An article in the November 20, 2008 edition of the New England Journal of Medicine reports the results from a large,
randomized study designed to assess the relationship between statin treatment and cardiovascular disease (as indicated
by having at least one of several clinical endpoints).
The researchers randomized 17,800 healthy (without a history of cardiovascular disease) men and women with non-
elevated LDL cholesterol levels to either 20 mg of statins daily, or placebo. Subjects were followed for up to 5 years. At the
end of the follow-up period the study results included the following:
Of the 8900 subjects randomized to the statins group, 142 developed cardiovascular disease. Of the 8900 subjects
randomized to the placebo group, 251 developed cardiovascular disease.
(Reference: Ridker P, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein.
New England Journal of Medicine. (2008). 359;21)
What is the estimated relative risk of developing cardiovascular disease for subjects in the statins group
compared to subjects on placebo?
The estimated relative risk is approximately - 0.012.
The estimated relative risk is approximately 1.77
The estimated relative risk is approximately 0.57.
The estimated relative risk is approximately 0.012.
Transcribed Image Text:7. An article in the November 20, 2008 edition of the New England Journal of Medicine reports the results from a large, randomized study designed to assess the relationship between statin treatment and cardiovascular disease (as indicated by having at least one of several clinical endpoints). The researchers randomized 17,800 healthy (without a history of cardiovascular disease) men and women with non- elevated LDL cholesterol levels to either 20 mg of statins daily, or placebo. Subjects were followed for up to 5 years. At the end of the follow-up period the study results included the following: Of the 8900 subjects randomized to the statins group, 142 developed cardiovascular disease. Of the 8900 subjects randomized to the placebo group, 251 developed cardiovascular disease. (Reference: Ridker P, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine. (2008). 359;21) What is the estimated relative risk of developing cardiovascular disease for subjects in the statins group compared to subjects on placebo? The estimated relative risk is approximately - 0.012. The estimated relative risk is approximately 1.77 The estimated relative risk is approximately 0.57. The estimated relative risk is approximately 0.012.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Research Ethics
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
MATLAB: An Introduction with Applications
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman